Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance

The development of drug resistance remains a major challenge in cancer treatment. Ferroptosis, a unique type of regulated cell death, plays a pivotal role in inhibiting tumour growth, presenting new opportunities in treating chemotherapeutic resistance. Accumulating studies indicate that epigenetic...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer Vol. 23; no. 1; pp. 177 - 22
Main Authors Wang, Hongquan, Fleishman, Joshua S., Cheng, Sihang, Wang, Weixue, Wu, Fan, Wang, Yumin, Wang, Yu
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 27.08.2024
BioMed Central
BMC
Subjects
Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
Cancer
Cell death
Chemotherapy
Development and progression
Drug resistance
Drug Resistance, Neoplasm - genetics
Drug therapy
Epigenesis, Genetic
Epigenetic inheritance
Ferroptosis
Ferroptosis - drug effects
Ferroptosis - genetics
Gene Expression Regulation, Neoplastic - drug effects
Humans
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Non-coding RNAs
Review
RNA, Untranslated - genetics
Non-coding RNAs
Ferroptosis
Drug resistance
Cancer
Online AccessGet full text

Cover

More Information
Summary:The development of drug resistance remains a major challenge in cancer treatment. Ferroptosis, a unique type of regulated cell death, plays a pivotal role in inhibiting tumour growth, presenting new opportunities in treating chemotherapeutic resistance. Accumulating studies indicate that epigenetic modifications by non-coding RNAs (ncRNA) can determine cancer cell vulnerability to ferroptosis. In this review, we first summarize the role of chemotherapeutic resistance in cancer growth/development. Then, we summarize the core molecular mechanisms of ferroptosis, its upstream epigenetic regulation, and its downstream effects on chemotherapeutic resistance. Finally, we review recent advances in understanding how ncRNAs regulate ferroptosis and from such modulate chemotherapeutic resistance. This review aims to enhance general understanding of the ncRNA-mediated epigenetic regulatory mechanisms which modulate ferroptosis, highlighting the ncRNA-ferroptosis axis as a key druggable target in overcoming chemotherapeutic resistance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1476-4598
1476-4598
DOI:10.1186/s12943-024-02088-7